Note*: This report requires 7-10 business days to complete.
DelveInsight’s Migraine - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Migraine forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Migraine till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Migraine market.
• Identifying patient populations in the global “Migrainemarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Migraine therapeutics in each of the markets covered.
• To understand the future market competition in the global Migraine therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Migraine for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Migraine overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Migraine Market
• Global Epidemiology of Migraine Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Migraine Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Migraine (2013-2023)
• Table 7: Migraine Global Market (USD Millions), (2013-2015)
• Table 8: Migraine Global Market (USD Millions), (2016-2023)
• Table 9: Migraine US Market (USD Millions), (2013-2015)
• Table 10: Migraine US Market (USD Millions), (2016-2023)
• Table 11: Migraine Germany Market (USD Millions), (2013-2015)
• Table 12: Migraine Germany Market (USD Millions), (2016-2023)
• Table 13: Migraine United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Migraine United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Migraine France Market (USD Millions), (2013-2015)
• Table 16: Migraine France Market (USD Millions), (2016-2023)
• Table 17: Migraine Italy Market (USD Millions), (2013-2015)
• Table 18: Migraine Italy Market (USD Millions), (2016-2023)
• Table 19: Migraine Spain Market (USD Millions), (2013-2015)
• Table 20: Migraine Spain Market (USD Millions), (2016-2023)
• Table 21: Migraine Japan Market (USD Millions), (2013-2015)
• Table 22: Migraine Japan Market (USD Millions), (2016-2023)
• Table 23: Migraine ROW Market (USD Millions), (2013-2015)
• Table 24: Migraine ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Migraine Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Migraine (2013-2023)
• Figure 3: Migraine Global Market (USD Millions), (2013-2015)
• Figure 4: Migraine Global Market (USD Millions), (2016-2023)
• Figure 5: Migraine US Market (USD Millions), (2013-2015)
• Figure 6: Migraine US Market (USD Millions), (2016-2023)
• Figure 7: Migraine Germany Market (USD Millions), (2013-2015)
• Figure 8: Migraine Germany Market (USD Millions), (2016-2023)
• Figure 9: Migraine United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Migraine United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Migraine France Market (USD Millions), (2013-2015)
• Figure 12: Migraine France Market (USD Millions), (2016-2023)
• Figure 13: Migraine Italy Market (USD Millions), (2013-2015)
• Figure 14: Migraine Italy Market (USD Millions), (2016-2023)
• Figure 15: Migraine Spain Market (USD Millions), (2013-2015)
• Figure 16: Migraine Spain Market (USD Millions), (2016-2023)
• Figure 17: Migraine Japan Market (USD Millions), (2013-2015)
• Figure 18: Migraine Japan Market (USD Millions), (2015-2023)
• Figure 19: Migraine ROW Market (USD Millions), (2013-2015)
• Figure 20: Migraine ROW Market (USD Millions), (2016-2023)
• GlaxoSmithKline
• AstraZeneca
• Merck
• VernalisAlmirall
• Pfizer
• Zogenix
• NuPathe
• Allergan
• RedHill BiopharmaOptiNose
• CoLucid Pharmaceuticals
• SUDA
• Revance Therapeutics
• NeurAxon
